Detalles de la búsqueda
1.
Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort study.
Cancer;
129(13): 2013-2022, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951498
2.
A 7-Day Decitabine-Included Conditioning Regimen Accelerated Donor Hematopoietic Engraftment while Reduced the Occurrence of Mucositis without Interfering with Prognosis.
Chemotherapy;
68(3): 143-154, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36990070
3.
Conditioning Regimen of 5-Day Decitabine Administration for Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome and Myeloproliferative Neoplasms.
Biol Blood Marrow Transplant;
26(2): 285-291, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31494229
4.
Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.
Chin Med J (Engl);
128(15): 2065-71, 2015 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26228220
Resultados
1 -
4
de 4
1
Próxima >
>>